Larimar Therapeutics
demographics of phase cohort parameter ant als | Larimar Therapeutics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
36 of 44
Related slides by other companies
Ocuphire Pharma
Results
January 2023
zeta demographics | Ocuphire Pharma
DICE Therapeutics
Investor Presentation
March 2023
phase demographics and disease characteristics dice | DICE Therapeutics
BioAtla
Investor Presentation
January 2024
phase cab demographics tumor types | BioAtla
Ocuphire Pharma
Investor Day
January 2022
characteristics for zeta trial interim | Ocuphire Pharma
Other recent decks by Larimar Therapeutics
See all presentations (3 decks)
Results
November 2022
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights